Table 2.
Schedule of PESAPRO study’s visit
| Visit 1 (Routine control 2 term)a | Inform Visit | Visit 0 basal (20 weeks + 1 to 23 weeks + 6) | Visit 1 (V0 + 4 weeks) | Visit 2 (V1 + 4 weeks) | Visit 3 (V2 + 4 weeks) | Visit 4 (EOT) (37 weeks to 37 weeks + 4) | Post-delivery visit (4 to 6 weeks post-delivery) | |
|---|---|---|---|---|---|---|---|---|
| Eligibility criteria | √ | √ | ||||||
| Informed consent | √ | |||||||
| Randomization and start of treatment | √ | |||||||
| Blood pressure/ weight | √ | √ | √ | √ | √ | |||
| Vaginal culture | √ | |||||||
| Manual vaginal exam | √ | √ | ||||||
| Cervicometry | √ | √ | √ | √ | √ | √ | ||
| Follow-up Questionnaire | √ | √ | √ | √ | ||||
| Basic fetal US | √ | √ | √ | √ | ||||
| End of treatment (EOT) | √ | |||||||
| Review maternal medical history | √ | √ | ||||||
| Review neonate medical history | √ |
aThis visit is a routine (“standard of care”) visit in the control of pregnancy. Patients with a short cervix are invited to an extra visit (for information) before being enrolled in the study